• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Investigation of the treatment for gastrointestinal cancers and gastrointestinal stromal tumors using the glucose transporter 1 inhibitor.

Research Project

Project/Area Number 19K09199
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 55020:Digestive surgery-related
Research InstitutionKumamoto University

Principal Investigator

Sawayama Hiroshi  熊本大学, 病院, 助教 (40594875)

Co-Investigator(Kenkyū-buntansha) 石本 崇胤  熊本大学, 病院, 特任准教授 (00594889)
清住 雄希  熊本大学, 病院, 非常勤診療医師 (30827324)
岩槻 政晃  熊本大学, 大学院生命科学研究部(医), 助教 (50452777)
宮本 裕士  熊本大学, 病院, 講師 (80551259)
Project Period (FY) 2019-04-01 – 2022-03-31
Project Status Completed (Fiscal Year 2021)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2021: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2020: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2019: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Keywords消化管癌 / GIST / 抗癌剤感受性 / GLUT1阻害剤 / BAY-876 / GLUT1 / Glycolysis / 食道扁平上皮癌 / 細胞周期 / 消化管GIST / SGLT2阻害剤
Outline of Research at the Start

GLUT1は多くの癌腫で発現上昇を認め、癌の糖代謝において重要な役割を担っている。GLUT1阻害剤は、In vivoにおいて増殖抑制効果を示し、投与後高血糖や体重減少を認めたが致死的有害事象はなく臨床応用が望まれる。我々は、消化管癌、GISTにおいてGLUT1の発現抑制による増殖抑制効果を示してきた。近年GLUT1に親和性が高く低濃度で作用する低分子化合物が開発された。本研究によりGLUT1阻害剤の抗腫瘍効果、癌特異的代謝への影響を解明することで、糖代謝経路抑制による有害事象を克服し抗癌剤に抵抗性を示す消化管癌、GISTに対し、前臨床段階として新規治療法を提示できると考える。

Outline of Final Research Achievements

Cancer growth is reported to be dependent on glucose metabolism. We demonstrated that suppressing the expression of glucose transporter 1 (GLUT1), which is responsible for glucose uptake into cancer cells, had an inhibitory effect on proliferation in esophageal cancer cell lines. The expression of GLUT1 was associated with the sensitivity to cisplatin, a platinum-based anti-cancer drug, and suppressing GLUT1 expression improved the sensitivity to the anti-cancer drug. BAY-876, a specific inhibitor for GLUT1 at low concentrations, inhibited cell proliferation and had an additive effect with cisplatin. The expression of GLUT1 was associated with the therapeutic effect of anticancer drugs, in clinical specimens of esophageal squamous cell carcinoma.

Academic Significance and Societal Importance of the Research Achievements

抗癌剤治療において抗癌剤耐性機序の解明は重要な課題である。また、細胞障害性抗癌剤やがん遺伝子に対する分子標的療法が治療の中心であり新たな治療法の開発が望まれる。我々は、癌の糖代謝経路に関係するGLUT1が抗癌剤感受性の関係することを明らかにした。さらに、低濃度で作用するGLUT1阻害剤を用い、食道扁平上皮癌の増殖抑制効果を示した。本研究によって、抗癌剤感受性に関係する因子が明らかになり、糖代謝経路を標的とした新たな治療法の可能性を示した。

Report

(4 results)
  • 2021 Annual Research Report   Final Research Report ( PDF )
  • 2020 Research-status Report
  • 2019 Research-status Report
  • Research Products

    (11 results)

All 2021 2020 2019

All Journal Article (6 results) (of which Peer Reviewed: 6 results,  Open Access: 3 results) Presentation (5 results) (of which Int'l Joint Research: 1 results)

  • [Journal Article] Overall survival after recurrence in stage I-III colorectal cancer patients in accordance with the recurrence organ site and pattern2021

    • Author(s)
      Sawayama Hiroshi、Miyamoto Yuji、Hiyoshi Yukiharu、Ogawa Katsuhiro、Kato Rikako、Akiyama Takahiko、Kiyozumi Yuki、Yoshida Naoya、Baba Hideo
    • Journal Title

      Annals of Gastroenterological Surgery

      Volume: 5 Issue: 6 Pages: 813-822

    • DOI

      10.1002/ags3.12483

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Preoperative transferrin level is a novel indicator of short- and long-term outcomes after esophageal cancer surgery2021

    • Author(s)
      Yamane Taishi、Sawayama Hiroshi、Yoshida Naoya、Morinaga Takeshi、Akiyama Takahiko、Eto Kojiro、Harada Kazuto、Ogawa Katsuhiro、Iwatsuki Masaaki、Iwagami Shiro、Baba Yoshifumi、Miyamoto Yuji、Baba Hideo
    • Journal Title

      International Journal of Clinical Oncology

      Volume: 27 Issue: 1 Pages: 131-140

    • DOI

      10.1007/s10147-021-02031-6

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Minimally invasive esophagectomy may contribute to low incidence of postoperative surgical site infection in patients with poor glycemic control2021

    • Author(s)
      Yamane Taishi、Yoshida Naoya、Horinouchi Tomo、Morinaga Takeshi、Eto Kojiro、Harada Kazuto、Ogawa Katsuhiro、Sawayama Hiroshi、Iwatsuki Masaaki、Baba Yoshifumi、Miyamoto Yuji、Baba Hideo
    • Journal Title

      Langenbeck's Archives of Surgery

      Volume: 407 Issue: 2 Pages: 579-585

    • DOI

      10.1007/s00423-021-02306-6

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Preoperative iron status is a prognosis factor for stage II and III colorectal cancer2021

    • Author(s)
      Sawayama Hiroshi、Miyamoto Yuji、Mima Kosuke、Kato Rikako、Ogawa Katsuhiro、Hiyoshi Yukiharu、Shimokawa Mototsugu、Akiyama Takahiko、Kiyozumi Yuki、Iwagami Shiro、Iwatsuki Masaaki、Baba Yoshifumi、Yoshida Naoya、Baba Hideo
    • Journal Title

      International Journal of Clinical Oncology

      Volume: 26 Issue: 11 Pages: 2037-2045

    • DOI

      10.1007/s10147-021-01995-9

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Preoperative transferrin level is a novel prognostic marker for colorectal cancer2021

    • Author(s)
      Sawayama Hiroshi、Miyamoto Yuji、Hiyoshi Yukiharu、Shimokawa Mototsugu、Kato Rikako、Akiyama Takahiko、Sakamoto Yuki、Daitoku Nobuya、Yoshida Naoya、Baba Hideo
    • Journal Title

      Annals of Gastroenterological Surgery

      Volume: 5 Issue: 2 Pages: 243-251

    • DOI

      10.1002/ags3.12411

    • Related Report
      2021 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer2019

    • Author(s)
      Sawayama Hiroshi、Ogata Yoko、Ishimoto Takatsugu、Mima Kosuke、Hiyoshi Yukiharu、Iwatsuki Masaaki、Baba Yoshifumi、Miyamoto Yuji、Yoshida Naoya、Baba Hideo
    • Journal Title

      Cancer Science

      Volume: 110 Issue: 5 Pages: 1705-1714

    • DOI

      10.1111/cas.13995

    • Related Report
      2019 Research-status Report
    • Peer Reviewed / Open Access
  • [Presentation] 大腸癌における術前血清鉄と全生存期間および腸内細菌に関する検討2021

    • Author(s)
      澤山 浩, 宮本 裕士, 美馬 浩介, 加藤 梨佳子, 秋山 貴彦, 坂本 悠樹, 大徳 暢哉, 問端 輔,  中村 健一, 岩槻 政晃, 馬場 祥史, 吉田 直矢, 馬場 秀夫
    • Organizer
      第121回日本外科学会定期学術集会
    • Related Report
      2021 Annual Research Report
  • [Presentation] 消化管癌における術前トランスフェリンと術後長期成績の関係に関する検討2021

    • Author(s)
      澤山 浩, 宮本 裕士, 小川 克大, 加藤 梨佳子, 中村 健一, 岩槻 政晃, 岩上 志朗, 馬場 祥史, 吉田 直矢, 馬場 秀夫
    • Organizer
      JDDW
    • Related Report
      2021 Annual Research Report
  • [Presentation] 糖尿病を有する大腸癌Stage I-III患者の臨床病理学的背景、術後合併症、長期予後に関する検討2021

    • Author(s)
      澤山 浩, 宮本 裕士, 小川 克大, 加藤 梨佳子, 森永 剛司, 山根 大侍, 秋山 貴彦, 中村 健一, 原田 和人, 岩槻 政晃, 岩上 志朗, 馬場 祥史, 吉田 直矢, 馬場 秀夫
    • Organizer
      消化器病学会九州支部例会
    • Related Report
      2021 Annual Research Report
  • [Presentation] 食道扁平上皮癌におけるGLUT1発現と腫瘍増殖およびCDDP感受性の関係に関する検討2020

    • Author(s)
      澤山 浩, 石本 崇胤, 吉田 直矢, 日吉 幸晴, 岩槻 政晃, 宮本 裕士, 平尾 洸樹, 坂田 和也, 高田登, 吉仲 一郎, 原田 和則, 馬場 秀夫
    • Organizer
      第120回日本外科学会定期学術集会
    • Related Report
      2020 Research-status Report 2019 Research-status Report
  • [Presentation] Glucose Transporter 1 regulate cell glycolysis and proliferation in Gastrointestinal stromal tumor and its clinicopathological significance.2020

    • Author(s)
      Masaaki Iwatsuki, Hiroshi Sawayama, Daisuke Kuroda, Yuki Koga, Kazuto Harada, Kohei Yamashita, Shiro Iwagami, Kojiro Eto, Takatsugu Ishimoto, Yoshifumi Baba, Naoya Yoshida, Jaffer A. Ajani and Hideo Baba
    • Organizer
      2019 AACR Annual Meeting
    • Related Report
      2019 Research-status Report
    • Int'l Joint Research

URL: 

Published: 2019-04-18   Modified: 2023-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi